Filter articles using the following links

GenSight Biologics to Present New Clinical Data of LUMEVOQ® and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting

GenSight Biologics Reports Cash Position as of September 30, 2021 and Provides Operational Update

GenSight Biologics Provides Update on Manufacturing Timeline Needed for LUMEVOQ® Regulatory Filing

Cell UK by Oxford’s Global, London (UK) & Virtual

BIO-Europe 2021, Virtual

GenSight Biologics Announces FDA Grant of Fast Track Designation for Optogenetic Therapy GS030 as Treatment for Retinitis Pigmentosa

Mitochondrial Diseases Conference 2021 by Mitocon, Virtual

28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), Virtual

2021 ARM Cell & Gene Meeting on the Mesa, Carlsbad, CA (USA) & Virtual

39th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS), San Antonio, TX (USA)